FDA Issues New Guidance on Cell, Gene, and Regenerative Therapies

Published on RAPS

The US FDA has released updated guidance documents covering cell and gene therapies and regenerative medicine. These resources aim to clarify regulatory expectations for developers and strengthen pathways for safe and effective innovation in the field.

👉 Read the full article: FDA Issues Guidances on CGT, Regenerative Medicine

Disclaimer

Images used are for illustrative purposes only and do not depict actual persons, products, or facilities. For full detail, refer to the original article via the provided link. SSCTR does not provide medical advice, and the views expressed are for educational purposes only.